Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3111

Latin America Oncology Drugs Market by Therapy Modality (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy, and Others) and by Type of cancer (Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, Skin Cancer, and Others) - Opportunity Analysis and Industry Forecast, 2017-2023

LI 172864
Pages: NA
Apr 2018 | 673 Views
face gplus_n
Author's : NA
Tables: NA
Charts: NA
twit_n pr_n

Oncology drugs include chemotherapy, hormone therapy, immunotherapy, and other drugs that are useful in the treatment of cancer. According to the CDC, 21.1 million adults were diagnosed with cancer in 2015, which drives the number of oncologic drugs in the market. Whereas in Latin America and the Caribbean about 1.1 million new cancer cases and 600,000 cancer deaths are estimated to occur annually.

Increase in prevalence in cancer, growth in population and more dispatchable money with the older section of the society, and rise in awareness about the treatments, technologies, and the disease itself drive the market growth. However, the high cost involved in new drug development coupled with threat of failure and adverse effects associated with anti-cancer drugs therapies restrain the growth of the market. Nevertheless, advancements in cancer drug research owing to biological/targeted therapies and personalized medicines make way for promising opportunities for pharmaceutical, bio-pharmaceutical, and biotechnology companies engaged in developing cancer drugs.

The Latin America oncology drugs market is segmented on the basis of therapy modality, types of cancer, and country. Based on therapy modalities, the market is divided into chemotherapy, targeted therapy, immunotherapy (biologic therapy), hormonal therapy, and others. By type of cancer, the market is classified into blood cancer, breast cancer, gastrointestinal cancer, respiratory/lung cancer, skin cancer and other cancers. Based on country, the market is studied across Brazil, Argentina, Columbia, Chile, and Peru.

The companies operating in the market are Novartis A.G, F. Hoffmann-La Roche Ltd, Medley Genomics, Eurofarma Laboratrios S.A., Ach Laboratrios Farmacuticos S.A., Laboratorios IMA, Laboratrio Cristlia, Icon Plc., Sanofi S.A, and Laboratoires Pierre Fabre.

Key Benefits

  • The study provides an in-depth analysis of the Latin America oncology drug market along with current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of the market by product type elucidates the various forms of available oncology drugs.
  • Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.
  • By geography, the market is analyzed across Latin America such as Brazil, Argentina, Columbia, Peru, and Chile.

Latin America Oncology Drugs Market Key Segments:

By Therapy Modalities

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
  • Others

By Types of Cancer

  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Respiratory/Lung Cancer
  • Skin Cancer
  • Other Cancers

By Country

  • Brazil
  • Argentina
  • Columbia
  • Chile
  • Peru
  • Other Latin America Countries
 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 

Get More Information About This Report

For any queries about purchasing this report, Please fill the form below:

Please input the above text in the input box or click refresh

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts